EG: Leisure Property Leads the Way in 2020 Sector Enquiries
EG: Leisure Property Leads the Way in 2020 Sector Enquiries Enquiry data gathered from EG Propertylink shows that while the first lockdown of 2020 dramatically impacted enquiries for commercial property it was searches for leisure and retail space which saw the biggest increase once restrictions started to lift.
Key findings from the report include: – Between the first and second lockdown (June to October) enquiries for property in the leisure sector rose by 64%. This was closely followed by retail and office enquiries which grew by 62% and 56% respectively. – Enquiry data for 3 out of 4 key London commuter towns examined in the report shows that enquiries for retail property as a proportion of total property searches increased in November compared to January.
(Paris:TNG)
(Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, today announces that a first patient with head and neck cancer has been dosed with the Company’s innovative individualized immunotherapy, TG4050. This novel therapeutic vaccine is based on Transgene’s
myvac® technology platform, which leverages cutting-edge Artificial Intelligence (AI) capabilities to customize the treatment for each patient.
This innovative approach combines Transgene’s expertise in virus-based immunotherapies, NEC’s longstanding AI technologies and the commitment of prestigious cancer care centers.
THE FIRST PATIENT HAS BEEN DOSED AT THE IUCT ONCOPOLE IN TOULOUSE, France,
Transgene (Paris:TNG)
(Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, today announces that a first patient with head and neck cancer has been dosed with the Company’s innovative individualized immunotherapy, TG4050. This novel therapeutic vaccine is based on Transgene’s
myvac® technology platform, which leverages cutting-edge Artificial Intelligence (AI) capabilities to customize the treatment for each patient.
This innovative approach combines Transgene’s expertise in virus-based immunotherapies, NEC’s longstanding AI technologies and the commitment of prestigious cancer care centers.
THE FIRST PATIENT HAS BEEN DOSED AT THE IUCT ONCOPOLE IN TOULOUSE, France,
Loading video.
VIDEO: Alexander Stremitzer discusses the legal implications for physicians of following artificial intelligence advice in this new video from The Journal of Nuclear Medicine. view more
Credit: Video created by Alexander Stremitzer and Eidgenössische Technische Hochschule Zürich Center for Law and Economics.
Reston, Virginia Physicians who follow artificial intelligence (AI) advice may be considered less liable for medical malpractice than is commonly thought, according to a new study of potential jury candidates in the U.S. Published in the January issue of
The Journal of Nuclear Medicine (JNM). The study provides the first data related to physicians potential liability for using AI in personalized medicine, which can often deviate from standard care.